Literature DB >> 11591716

Poxvirus infection rapidly activates tyrosine kinase signal transduction.

J Masters1, A A Hinek, S Uddin, L C Platanias, W Zeng, G McFadden, E N Fish.   

Abstract

Viruses have evolved a number of strategies to gain entry and replicate in host target cells that, for human immunodeficiency virus (HIV) and the poxvirus, myxoma virus, involve appropriating chemokine receptors. In this report we demonstrate that activation of multiple intracellular tyrosine phosphorylation events rapidly ensues following virus adsorption to NIH 3T3.CD4.CCR5 cells and affects the ultimate level of myxoma virus replication. UV-inactivated myxoma virus induces the rapid phosphorylation of CCR5 on tyrosine residues, the association of CCR5 with Jaks and p56(lck), and their phosphorylation-activation within minutes of virus adsorption. Additionally, we provide evidence for myxoma virus-inducible signal transducers and activators of transcription (Stat) and insulin receptor substrate (IRS) activation. In contrast to CCR5 activation effected by HIV Env protein, these myxoma virus-inducible phosphorylation events are not sensitive to pertussis toxin treatment. Moreover, in cells that are non-permissive for myxoma virus infection, we provide evidence that myxoma virus fails to invoke this tyrosine phosphorylation cascade. Consistent with the observation that infection of CCR5-expressing cells is blocked by herbimycin A and the Jak 2 inhibitor, tyrophostin AG490, we infer that viral infectivity may be dependent on non-G-protein-coupled signal transduction pathways triggered by the infecting myxoma virus particle. This provides a novel post-binding mechanism by which viruses can co-opt a cellular receptor to permit productive virus infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591716     DOI: 10.1074/jbc.M108019200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication.

Authors:  Ramtin Rahbar; Thomas T Murooka; Anna A Hinek; Carole L Galligan; Antonella Sassano; Celeste Yu; Kishore Srivastava; Leonidas C Platanias; Eleanor N Fish
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Role for CCR5 in dissemination of vaccinia virus in vivo.

Authors:  Ramtin Rahbar; Thomas T Murooka; Eleanor N Fish
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

3.  Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.

Authors:  Ann Chahroudi; Rahul Chavan; Natalia Kozyr; Natalia Koyzr; Edmund K Waller; Guido Silvestri; Mark B Feinberg
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species.

Authors:  C R Carmo; P J Esteves; N Ferrand; W van der Loo
Journal:  Immunogenetics       Date:  2006-04-05       Impact factor: 2.846

5.  Role of the serine-threonine kinase PAK-1 in myxoma virus replication.

Authors:  J B Johnston; John W Barrett; Wen Chang; Che-Sheng Chung; Wei Zeng; Jennefer Masters; Melissa Mann; Fuan Wang; Jingxin Cao; Grant McFadden
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Authors:  Raymond S Weinstein; Michael M Weinstein; Kenneth Alibek; Michael I Bukrinsky; Beda Brichacek
Journal:  BMC Immunol       Date:  2010-05-18       Impact factor: 3.615

Review 7.  An emerging role for p21-activated kinases (Paks) in viral infections.

Authors:  Celine Van den Broeke; Maria Radu; Jonathan Chernoff; Herman W Favoreel
Journal:  Trends Cell Biol       Date:  2010-01-12       Impact factor: 20.808

8.  SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.

Authors:  Chulbul M Ahmed; Rea Dabelic; Lilian W Waiboci; Lindsey D Jager; Linda L Heron; Howard M Johnson
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

9.  Ligand-induced and nonfusogenic dissolution of a viral membrane.

Authors:  Mansun Law; Gemma C Carter; Kim L Roberts; Michael Hollinshead; Geoffrey L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

10.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.